News Focus
News Focus
Followers 22
Posts 4660
Boards Moderated 0
Alias Born 01/27/2022

Re: Tatsumaki post# 418606

Monday, 12/04/2023 4:39:37 PM

Monday, December 04, 2023 4:39:37 PM

Post# of 447426
Tats, I agree. Marketing/PR has been a massive, unmitigated failure by Amarin. JT operated under the premise that Vascepa would "sell itself", and nobody has effectively fixed that since.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News